| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT03684785 | Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors | TERMINATED | PHASE1, PHASE2 | 2018-12-13 | 2022-03-30 | 2022-03-30 |
| NCT03086278 | A Study of AST-008 in Healthy Subjects | COMPLETED | PHASE1 | 2017-10-20 | 2018-08-16 | 2018-08-16 |